MeiraGTx Holdings (MGTX) FCF Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) reported FCF Margin of 61.46% for Q4 2025, up 17597.0% on a YoY basis from N/an in Q4 2024, and up 101.97% quarter-over-quarter from 3121.95% in Q3 2025.
MeiraGTx Holdings (MGTX) FCF Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings has reported FCF Margin for 7 years, with the latest figure at 61.46% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin rose 17597.0% year-over-year to 61.46%; the trailing twelve-month figure through Dec 2025 stood at 49.8% (up 27909.0% YoY), and the FY2025 full-year result was 61.71%, up 26718.0% from the prior year.
- FCF Margin for Q4 2025 stood at 61.46%, up from 3121.95% in the prior quarter.
- The five-year high for FCF Margin was 468.21% in Q4 2022, with the low at 7370.57% in Q2 2024.
- Historically, FCF Margin has averaged 1213.94% across 5 years, with a median of 524.55% in 2021.
- Annual changes were most pronounced in 2024 — FCF Margin tumbled 641048 bps — and 2025, when it surged 614580 bps.
- MeiraGTx Holdings' FCF Margin stood at 26.33% in 2021, then jumped by 1878 bps to 468.21% in 2022, then plunged by 284 bps to 861.62% in 2023, then soared by 87 bps to 114.51% in 2024, then surged by 154 bps to 61.46% in 2025.
- The last three FCF Margin figures came in at 61.46% (Q4 2025), 3121.95% (Q3 2025), and 1224.76% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 61.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.46% |
| Sep 30, 2025 | -3,121.95% |
| Jun 30, 2025 | -1,224.76% |
| Dec 31, 2024 | -114.51% |
| Sep 30, 2024 | -236.04% |
| Jun 30, 2024 | -7,370.57% |
| Mar 31, 2024 | -5,512.05% |
| Dec 31, 2023 | -861.62% |
| Sep 30, 2023 | -548.27% |
| Jun 30, 2023 | -960.08% |
| Mar 31, 2023 | -1,379.63% |
| Dec 31, 2022 | 468.21% |
| Sep 30, 2022 | -638.23% |
| Jun 30, 2022 | -388.58% |
| Mar 31, 2022 | -368.51% |
| Dec 31, 2021 | -26.33% |
| Sep 30, 2021 | -418.65% |
| Jun 30, 2021 | -524.55% |
| Mar 31, 2021 | 99.76% |
| Dec 31, 2020 | -992.00% |